Exact FDA event identifier

Event 98165

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: December 22, 2025
Product types: Drug
Classifications: Class I
Statuses: Ongoing
Recalling firm wording: HANDELNINE GLOBAL LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

D-0332-2026

Recall number: D-0332-2026
Initiated: December 22, 2025
Classification: Class I
Status: Ongoing
Recalling firm: HANDELNINE GLOBAL LLC
Quantity: 4 bottles /30 capsules each

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: product found to contain lead.

Code information

Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028

Distribution pattern

Product was distributed to one customer in NY.